Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications.
Kemna EH, Tjalsma H, Podust VN, Swinkels DW
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of freeze-thaw cycling, storage and circadian rhythms on hepcidin in urine and serum.
Summary of Findings
Hepcidin-25 was detected in both serum and urine, but hepcidin-22 was only found in urine. Slight and inconsistent decreases were found in serum hepcidin levels after freeze-thaw cycling, but urine hepcidin consistently decreased after freeze-thaw cycling. The authors report that hepicidin in urine and serum was stable at -80 degrees C, but levels declined during 6 months of storage at -20 degrees C, even in the presence of PMSF. Serum levels of hepcidin peaked between 3 and 7 PM and were lowest between 3 and 6 AM, but urine levels of hepcidin showed only slight changes with circadian rhythms. Serum iron levels showed an inverse association with serum and urine hepcidin levels. Hepcidin concentrations were always lower when measured using the NP20 array compared to the IMAC30 array, and sensitivity was higher with the IMAC30 array. Concentrations of hepicidin in urine and serum were highest in patients with endotoxemia.
Biospecimens
FluidUrineFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
HemochromatosisOther diagnosesPlatforms
PeptideSELDI-TOF MSPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition EndotoxemiaIron-deficiency anemiaThalassemia majorBiospecimen Acquisition Biospecimen location SerumUrineBiospecimen Acquisition Time of biospecimen collection 12 AM12 PM3 AM3 PM6 AM6 PM9 AM9 PMStorage Freeze/thaw cycling 1 cycle2 cycles3 cycles4 cyclesStorage Storage duration 0 months6 monthsStorage Storage temperature -20 degrees C-80 degrees CAnalyte Extraction and Purification Protease inhibitor No protease inhibitor addedPMSFSELDI-TOF MS Specific Type of array IMAC30NP20